Intrinsiqs

Is Rein Therapeutics Inc. overvalued?

Rein Therapeutics Inc. (RNTX) — key valuation metrics and fundamentals.

No verdict
Price
$0.55
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$47.6M
Dividend yield
—
Return on equity
-234.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RNTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.